Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.
Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, Khandelwal P, MacMillan ML, Majhail N, Marks DI, Mehta P, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Qayed M, Rangarajan H, Ringden O, Saad A, Savani BN, Seo S, Shah A, Shah N, Schultz KR, Solh M, Spitzer T, Szer J, Teshima T, Verdonck LF, Williams KM, Wirk B, Wagner J, Yared JA, Weisdorf DJ. Mehta RS, et al. Among authors: holtan sg. Blood Adv. 2019 May 14;3(9):1441-1449. doi: 10.1182/bloodadvances.2018030171. Blood Adv. 2019. PMID: 31053571 Free PMC article.
The donor's dilemma.
Holtan SG, Weisdorf DJ. Holtan SG, et al. Blood. 2014 Jun 5;123(23):3538-9. doi: 10.1182/blood-2014-04-571661. Blood. 2014. PMID: 24904102 Free article. No abstract available.
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality.
MacMillan ML, Robin M, Harris AC, DeFor TE, Martin PJ, Alousi A, Ho VT, Bolaños-Meade J, Ferrara JL, Jones R, Arora M, Blazar BR, Holtan SG, Jacobsohn D, Pasquini M, Socie G, Antin JH, Levine JE, Weisdorf DJ. MacMillan ML, et al. Among authors: holtan sg. Biol Blood Marrow Transplant. 2015 Apr;21(4):761-7. doi: 10.1016/j.bbmt.2015.01.001. Epub 2015 Jan 10. Biol Blood Marrow Transplant. 2015. PMID: 25585275 Free PMC article.
Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.
Ustun C, Trottier BJ, Sachs Z, DeFor TE, Shune L, Courville EL, Holtan SG, Dolan M, Weisdorf DJ, Warlick ED. Ustun C, et al. Among authors: holtan sg. Biol Blood Marrow Transplant. 2015 May;21(5):866-72. doi: 10.1016/j.bbmt.2015.01.017. Epub 2015 Jan 22. Biol Blood Marrow Transplant. 2015. PMID: 25620751 Free PMC article.
Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.
Bejanyan N, Rogosheske J, DeFor T, Lazaryan A, Esbaum K, Holtan S, Arora M, MacMillan ML, Weisdorf D, Jacobson P, Wagner J, Brunstein CG. Bejanyan N, et al. Biol Blood Marrow Transplant. 2015 May;21(5):926-33. doi: 10.1016/j.bbmt.2015.01.023. Epub 2015 Feb 3. Biol Blood Marrow Transplant. 2015. PMID: 25655791 Free PMC article. Clinical Trial.
Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.
Holtan SG, Verneris MR, Schultz KR, Newell LF, Meyers G, He F, DeFor TE, Vercellotti GM, Slungaard A, MacMillan ML, Cooley SA, Blazar BR, Panoskaltsis-Mortari A, Weisdorf DJ. Holtan SG, et al. Biol Blood Marrow Transplant. 2015 Jun;21(6):1029-36. doi: 10.1016/j.bbmt.2015.02.018. Epub 2015 Mar 7. Biol Blood Marrow Transplant. 2015. PMID: 25759146 Free PMC article. Clinical Trial.
179 results